Through his studies on cancer-causing viruses, the University of California, Los Angeles, professor has helped develop lifesaving treatments.

Targeting the transient group of cells could prevent recurrence of the disease.

Combining data from the genetic testing techniques can guide patient care, scientists say.

An investigation by Politico finds the agency has been sitting on an assessment of formaldehyde’s cancer risks for a year and a half.

Early exposure to common microbes could stop leukemia from manifesting in children.

Mutations in the TP53 gene appear to influence the prognosis and likelihood of future cancers in pediatric leukemia patients.

Two large-scale studies reveal new insights into the genomic characteristics of childhood cancers.

The immunotherapy, which targets CD22 on cancer cells rather than CD19, might prove useful in patients for whom previous T-cell treatments were unsuccessful. 

The genetically modified blood cells will be used for patients with a type of acute lymphoblastic leukemia, when other treatments fail.